Childhood encephalopathies and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disorders.
OBJECTIVE
To assess the frequency of mitochondrial abnormalities in muscle histology, defects in respiratory chain enzyme activities, and mutations in mitochondrial DNA (mtDNA) in children with unexplained psychomotor retardation in the population of Northern Finland.


BACKGROUND
The frequency of mitochondrial diseases among patients with childhood encephalopathies and myopathies is not known. Frequencies are difficult to estimate because the clinical presentation of these disorders is variable.


METHODS
A total of 116 consecutive patients with undefined encephalopathies and myopathies were enrolled during a 7-year period in a hospital serving as the only neurologic unit for a pediatric population of 97 609 and as the only tertiary level neurologic unit for a pediatric population of 48 873. Biochemical and morphologic investigations were performed on muscle biopsy material, including oximetric and spectrophotometric analyses of oxidative phosphorylation, histochemistry, electron microscopy, and molecular analysis of mtDNA.


RESULTS
Ultrastructural changes in the mitochondria were the most common finding in the muscle biopsies (71%). Ragged-red fibers were found in 4 cases. An oxidative phosphorylation defect was found in 26 children (28%), complex I (n = 15) and complex IV (n = 13) defects being the most common. Fifteen percent of patients (n = 17/116) with unexplained encephalomyopathy or myopathy had a probable mitochondrial disease. Common pathogenic mutations were found in the mtDNA of only 1 patient (.9%).


CONCLUSIONS
The common known mutations in mtDNA are rarely causes of childhood encephalomyopathies, which is in contrast to the considerable frequency of the common MELAS mutation observed among adults in the same geographical area. Biochemically and morphologically verified mitochondrial disorders were nevertheless common among the children, making the analysis of a muscle biopsy very important for clinical diagnostic purposes.
Uusimaa
J
J
Departments of Medical Biochemistry, University of Oulu, Finland.
Remes
A M
AM
Rantala
H
H
Vainionpää
L
L
Herva
R
R
Vuopala
K
K
Nuutinen
M
M
Majamaa
K
K
Hassinen
I E
IE
D000293:Adolescent; D000328:Adult; D001706:Biopsy; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D004272:DNA, Mitochondrial / Q000235:genetics; D005260:Female; D005387:Finland / Q000453:epidemiology; D005787:Gene Frequency / Q000235:genetics; D005828:Genetics, Population; D006801:Humans; D007223:Infant; D017241:MELAS Syndrome / Q000453:epidemiology / Q000235:genetics / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D008931:Mitochondria, Muscle / Q000473:pathology; D017237:Mitochondrial Encephalomyopathies / Q000453:epidemiology* / Q000235:genetics / Q000473:pathology; D018482:Muscle, Skeletal / Q000473:pathology; D011446:Prospective Studies
D004272:DNA, Mitochondrial